THE BRITISH SOCIETY FOR CELL BIOLOGY FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 Registered Charity number: 265816
JCS Accountants Limited 5 Robin Hood Lane Sutton Surrey SM1 2SW
THE BRITISH SOCIETY FOR CELL BIOLOGY
FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| Contents | Page |
|---|---|
| Officers and Advisers | 1 |
| Executive Committee’s Report | 2-7 |
| Independent Examiner’s Report | 8 |
| Statement of Financial Activities | 9 |
| Balance Sheet | 10 |
| Notes to the Financial Statements | 11-14 |
P a g e | 1
THE BRITISH SOCIETY FOR CELL BIOLOGY REFERENCE AND ADMINISTRATIVE DETAILS
Trustees/Officers:
Laura Machesky President Tobias Zech Treasurer Simon Allison Secretary Nathalie Signoret Membership Secretary Viji Draviam Meetings Secretary Helen Matthews Web and social media Officer Mattea Finelli Newsletter Secretary James Brown Newsletter Secretary
Trustees ending their term in 2025: Giampietro Schiavo (22.11.25) Treasurer Ciaran Morrison (22.11.25) Newsletter Secretary Tom Nightingale (22.11.25) Newsletter Secretary Other Executive Committee Members: Daniel Booth Honor Fell Secretary/Childcare Officer Tom McVicar Honor Fell Secretary/Childcare Officer Liz Miller Summer studentships Darius Koester Science advocacy/Outreach Officer Aymen al-Rawi Postdoc representative Harriet Smith PhD student representative Ye Dee Tay Education Strategy Officer Key Management Personnel: Laura Machesky President Tobias Zech Treasurer Simon Allison Secretary Bankers: HSBC Bank plc Arlington Business Centre Millshaw Park Lane Leeds LS11 0PA Virgin Money 7 Gold Street Northampton NN1 1EN Independent Examiner: Miriam Hickson CTA FCA JCS Accountants Ltd 5 Robin Hood Lane Sutton Surrey SM1 2SW Contact Address: C/O Prof T Zech Institute of System, Molecular and Integrative Biology University of Liverpool Crown Street L69 3BX
P a g e | 2
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
The Officers (who are the trustees of the Society for the purposes of charity law) have pleasure in presenting their report and the independently examined accounts of the Society for the year ended 31 December 2025. These accounts have been prepared in accordance with the Charities Act 2011, the Statement of Recommended Practice (Charities SORP 2019 (FRS102)), Financial Reporting Standard 102 (FRS 102); and the constitution of the Society.
Structure, Governance and Management
Officers and committee
Under the constitution of the Society, the Officers of the Society are a President, a Secretary, a Treasurer, a Meetings Convenor, a Membership Secretary, a Newsletter Editor and a Website Co-ordinator. There is also an Executive Committee of the Society consisting of the Officers and thirteen other elected members.
The Executive Committee is elected at the Annual General Meeting, with the Officers being elected by the Executive Committee and the President being nominated by the Executive Committee.
The trustees are trained by having an at least 1-year transition period in which case the new trustee shadows the previous trustee, thus ensuring they know how to fill the role.
The Executive Committee prepares the Agenda for meetings of the Society, and between meetings acts as necessary on behalf of the Society; reporting on any such actions to the next meeting of the Society.
The individuals who served as Officers and Executive Committee members during the year, and since the yearend, were as follows:
Prof C Morrison (Joined 2019) Dr T Nightingale (Joined 2020) Prof G Schiavo (Joined 2020) Prof V Draviam (Joined 2021) Dr D Koester (Joined 2021) Prof L Machesky (Joined 2022) Prof N Signoret (Joined 2022) Dr S Allison (Joined 2022) Dr D Booth (Joined 2022) Dr A al-Rawi (Joined 2023) Dr H Matthews (Joined 2023) Dr T McVicar (Joined 2023) Dr L Miller (Joined 2023) Dr James Brown (Joined 2024) Dr Mattea Finelli (Joined 2024) Ms Harriet Smith (Joined 2024) Dr Ye Dee Tay (Joined 2024) Prof Tobias Zech (Joined 2024)
P a g e | 3
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
(CONTINUED)
The Executive Committee members in office at the date of this report are detailed on the previous page. The Key Management Personnel of the charity as listed on page 1 are in charge of directing, controlling, running and operating the charity on a day-to-day basis. No remuneration is paid to any of the Key Management Personnel or the other trustees.
Constitution
The Society is constituted under a constitution executed in 1965 and amended in 2014, 2022 and 2025. The Society is a registered charity, number 265816.
Risk assessment
The major risks to which the Society is exposed, as identified by the Executive Committee, have been reviewed in the year and systems are in place to mitigate those.
As we are a society, one major risk is a drop in numbers of members. To mitigate this risk, we have introduced easier ways of maintaining membership via direct debit, and introductory packages for PhD students that include 3 years membership at reduced rate. We hope that once students see the benefit of membership they will continue once they graduate.
Objectives and Activities
The objects of the Society are to promote the advancement of research in relation to all branches of cell biology and to encourage the interchange of information and support career development. The Society generally aims to fulfil these objects by organising and sponsoring meetings each year on topics relevant to cell biology; funding travel grants to PhD students, postdoctoral scientists and group leaders; Funding training courses in Cell Biology for early career scientists; Funding summer studentships; Issuing a yearly newsletter and maintaining a website (www.bscb.org).
The Executive Committee confirm that they have had due regard to the guidance issued by the Charity Commission relating to public benefit.
Achievements and Performance
The Company of Biologists (CoB) awarded the BSCB with a Block Grant of £35,000 and an Operational Grant of £72,500 in 2025. The support provided by the CoB is vitally important for the BSCB and enables it to promote Cell Biology within the UK across schools, universities and to support the research community. After the worldwide COVID-19 pandemic, the BSCB has experienced sustained demands for travel grants and summer fellowships. In contrast, the requests for PI support and courses remain lower than before the pandemic.
Membership
At the end of 2025, the BSCB had 809 active members compared to 860 in March 2025. The BSCB is continuing to promote new membership initiatives to secure new members.
Scientific Networking
The BSCB has fully resumed its well-established function of organising scientific meetings for the Cell Biology community. In 2025, we co-hosted the Biologists@100 conference that was jointly organised by Company of Biologists; SEM, BSDB and BSCB at the ACC Liverpool. 585 attendees from 27 countries (6 continents) and 286 on-site posters.
In addition, we provided support for one-day national meetings via £1,500 grants. Selected reports from these smaller meetings will be published in the BCSB Magazine where they are widely accessible to all our members.
P a g e | 4
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
(CONTINUED)
Career development
BSCB postdoc and PhD representatives have established two prizes to recognize excellence at their career stages. At our last meeting, they have helped to select talks for the conference and organised an ECR ‘Scientific Speed Dating’ event that ran on the first day of the meeting, where people networked and had fun.
Summer Internships
These awards aim to encourage the very best undergraduate students to consider research careers in cell biology. Awards were based on competitive applications scored by by eight members of the BSCB committee. In 2025, we received 39 applications and chose 13 for funding. We confirmed the level of funding to £340/week (to be in line with the 2024 minimum wage for under 23s, which is £9.18/h for a 36.5 h week and increased living costs). Most projects (9 in total) were for 8 weeks. Once completed, each student generated a report that was published in our BSCB newsletter. In 2026, summer studentships will be adjusted to new minimum wage and be a maximum of 6 weeks.
Scientific Awards
We continued to promote Cell Biology by awarding prestigious scientific prizes at multiple career levels.
The Hooke medal is awarded to an outstanding cell biologist of either gender who started their own lab within the last 14 years. This year we awarded our Hooke Medal to Ian Ganley , a group leader at the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee. His research focus lies in understanding the regulation of autophagy, an intracellular “self-eating” pathway that prevents the accumulation of damaged and potentially toxic cellular components. The other BSCB senior award is the Women in Cell Biology (WICB) Early Career Medal , which was established in 2015 to mark the 50th anniversary of the founding of the BSCB. It is an annual prize awarded to an outstanding female cell biologist who has started her own research group in the UK within the last seven years. In 2025, the WICB award went to Helen Weavers , a group leader in the Faculty of Health and Life Sciences at the University of Bristol. Her research programme focuses on the molecular mechanisms enabling cells and tissues to from damage, with the aim of developing novel therapies for regenerative medicine. This BSCB award contributes to recognising women’s success and provides role models for future generations.
The BSCB Postdoctoral Researcher Medal Winner 2025 is Pamela Swiatlowska , a British Heart Foundation Fellow at the National Heart and Lung Institute at Imperial College London (ICL) and a visiting postdoctoral researcher at Queen Mary University London (QMUL). Pamela earned her PhD from ICL where she investigated mechanical properties of cardiac myocytes and then transitioned to a postdoctoral researcher role at New York University in 2019, before returning to the UK in 2020 at the QMUL School of Engineering and Material Science. She currently investigates how cells sense and respond to their mechanical environment using cross-disciplinary approaches, furthering our understanding on the impact of alterations in nuclear mechano-genomics in cardiovascular diseases. In addition, Pamela regularly participates in public engagement activities such as Festival of Communities and Pint of Science, and she is a strong advocate of promoting Women in Science activities.
Pei Yee Tey is the recipient of the 2025 Raff Medal BSCB PhD Award . Pei Yee’s PhD project in the laboratory of Sylvie Urbe and Michael Clague focuses on understanding how the transfer of ubiquitin to proteins, which sorts them towards endo-lysosomal degradation, affects the stability of a highly dynamic immune checkpoint receptor called CTLA4. This receptor negatively regulates T-cell signalling by removing shared ligands from antigen-presenting cells and therefore is paramount for the outcome of immune therapies. Pei Yee is passionate about communicating her research and she has been awarded best poster and best short talk prizes at national and international conferences.
The four winners were awarded their medals during the Biologists@100 conference. Further details of their work can be found on the BSCB website.
P a g e | 5
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
(CONTINUED)
We run two additional competitions each year which are open to junior scientists: the BSCB Science Writing Prize and BSCB Image Competition . This year, the winning image was submitted by Alvaro Castano (The Francis Crick Institute). The winning essay was submitted by Katie Birditt, a PhD student with Maura Malpetti at the Centre for Frontotemporal Dementia and Related Disorders of the University of Cambridge. Prizes for best posters at the Biologists@100 conference were awarded to Jashaswi Basu (IISER, Pune, India) for the PhD student category and to Asifa Islam (University of Nottingham) for the postdoctoral researcher category. The award (£1,000 maximum) is for attending a cell biology meeting.
Supporting attendance at scientific meetings
The Honor Fell Travel Awards have been extremely popular, enabling students and postdocs to attend meetings worldwide. We received 71 applications and were able to fund 48. These have been administered by Daniel Booth and Thomas McVicar. As mentioned before, we experienced an overwhelming interest for this scheme, with a total expenditure of £40,000 in 2025 (100% of allocated budget).
Our PI Support scheme is also very important. It enables PIs with limited or no funding to attend meetings to support their development. With the reduced award amount of £1,000 from £1,750, it was possible to award most applications.
Details of the application process for these CoB Award Schemes are provided on the website and in our BSCB Magazine.
Outreach Activities
Committee member Darius Koester from the University of Warwick is our Science Advocacy and Outreach Officer. Darius uses the email list of engaged BSCB members to coordinate our society’s responses to various governmental calls for consultation flagged up by the Royal Society of Biology. Key science policy information is shared with our membership via the website and magazine. Planned activities include the formulation of an official BSCB position towards supporting the value of preprints and their role in the scientific community, encouraging all members to adhere to the DORA guidelines and support open access models.
We published a new edition of the BSCB magazine in April 2025 to publicize the BSCB and our work. This edition, has been printed in more than 1,000 copies distributed to all members. It was also available at the Biologists@100 conference for attendees to pick up and take away.
Website and Social Media
The BSCB website (www.bscb.org) also allows members and the wider cell biology community to keep informed about our activities. We have almost completed the revamping of the BSCB website, a process coordinated by committee member Helen Matthews with the external support of the company Blue2/Altar. The new BSCB website will be directly linked to social media and will be more accessible to members with disabilities. The website will be much easier to maintain and update, a major shortcoming of the current BSCB website.
The BSCB committee has recently decided to enhance and broaden the visibility of the BSCB on social media by establishing a presence and put out scheduled social media posts across multiple platforms (BlueSky; LinkedIn; Instagram). To this end, the BSCB has created a working subgroup led by Helen Matthews, who has implemented these changes.
P a g e | 6
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
(CONTINUED)
Financial Review
Reserves
The Executive Committee regularly reviews the reserves of the charity to ensure that sufficient liquid funds are available for the Society to meet its ongoing obligations. The trustees require a level of unrestricted reserves of £125,000 to meet existing and committed expenditure in case income is not received. Total funds on 31 December 2025 were £245,664 (2024: 225,932 and 2023: £236,264).
Of these, £130,059 are currently deposited in a 95-day notice savings account whilst the remaining £126,058 are in current accounts. The Company of Biology has granted the BSCB the freedom to move funds across funding schemes, allowing maximum flexibility to BSCB activities.
Investment Policy
The Executive Committee’s policy at present is to invest in low-risk and reasonably liquid assets, so that funds are available to meet any unforeseen needs that arise because of meeting activities.
Future Plans
We are currently planning in person meetings for 2026-2027. The main 2026 Meeting will be the Dynamic Cell VI meeting jointly with the Biochemical Society, the Chinese Society for Cell Biology and Royal Microscopy Society in Reading in April.
Several one-day BSCB-sponsored meetings will also take place in 2026 e.g., Scottish Cell Biology meeting (Glasgow), UK Microtubule meeting (Edinburgh); Cell Motility Club Symposium (London), NeuroBioUK (tbc), UK Membrane Trafficking Meeting.
P a g e | 7
THE BRITISH SOCIETY FOR CELL BIOLOGY EXECUTIVE COMMITTEE’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2025
(CONTINUED)
Executive Committee’s Responsibilities
The Executive Committee is responsible for preparing the Annual Report and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.
Charity law requires the Executive Committee to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the Society and of the surplus or deficit for that period. In preparing those financial statements, the Executive Committee have:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgments and estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
The Executive Committee has overall responsibility for ensuring that the Society has an appropriate system of controls, financial and otherwise. It is also responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Society. It is also responsible for safeguarding the assets of the Society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Tobias Zech Trustee
Date: 27/05/2026
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF THE BRITISH SOCIEfY FOR CELL BIOLOGY I report to the eharty trustees on my examination of the accounts of the Trust (the Twsll fof the year ended 31 December 2025. Rosponslbllltles and ba818 of report As the charity's trustees you are responsible for the preParan of the ¥wunls in aordanCe wrth thè requirements of the Charities Act 2011 1.the ACYI. I report in respect of my examinat of the Trust's accounts as carried out under section 145 of the Act and in arrying out my examination I have folk)wed all the applicable Directions given by the Charity Commission under section 1451511bl ol the Act. Indepond•nt •xamln•f tst•m•nt I have completed my examinatson. I confim) Ihat no matters have come to my attention in conngclion wilh the examination giving me cause to believe that in any malenal respect.. accounting records were not kapt in respèel of thè Trust as r8quir8d by section 130 of the Act.. or the accounts do nol accord wilh those records., or the accounts do not comply with the applieable requifemenls concerning the form and content of aecounls sel out in the Charities IAccounls and Report) Regulations 2008 other than any requirement that the accounts give a'twe and fair vithv. whh is rbot a matter considered as part of an indapendenl examination., or the accounts have not been prepared in accordance with the methods and princples of Accounting and Reporting ty Charits.. Slalement of Reccmmended Practice applicable lo charities preparing their accounts in accordance with the Financ1 Reportsng Standard applicable in the UK and tha RepublK of Iroland IFRS 1021 I have no concems and have ¢omo across no other matters in connecb'on wrth the examinalM)n to which attention should be drawn in this report in order to enable 4 proper understanding of the accounts lo be reached. Miriam HkSOn CTA FCA JCS Accountants Ltd S Robin Hood Lane Sutton Surrey SM1 2SW Date. %1 JLLWX 20 1&
P a g e | 9
THE BRITISH SOCIETY FOR CELL BIOLOGY STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR TO 31 DECEMBER 2025
| Note | Unrestricted | Unrestricted | Restricted | Total 2025 | Total 2025 | Unrestricted | Unrestricted | Restricted | Restricted | Total 2024 | Total 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Funds | Funds | Funds | Funds | |||||||||
| Income from: | £ | £ | £ | £ | £ | £ | ||||||
| Grants | 2 | 35,000 | 72,500 | 107,500 | 35,000 | 62,500 | 97,500 | |||||
| Investments | 3,855 | - | 3,855 | 2,413 | - | 2,413 | ||||||
| Charitable activities | ||||||||||||
| Subscriptions | 26,434 | - | 26,434 | 26,110 | - | 26,110 | ||||||
| Other income | 600 | - | 600 | - | - | - | ||||||
| Total income | 65,889 | 72,500 | 138,389 | 63,523 | 62,500 | 126,023 | ||||||
| Expenditure on: | ||||||||||||
| Charitable activities | ||||||||||||
| Grants payable: | ||||||||||||
| CoB | 4 | - | 45,603 | 45,603 | - | 48,486 | 48,486 | |||||
| Other grants | 9,319 | - | 9,319 | 6,244 | - | 6,244 | ||||||
| Studentships | 32,300 | - | 32,300 | 30,107 | - | 30,107 | ||||||
| Medals | 1,848 | - | 1,848 | 4,732 | - | 4,732 | ||||||
| Costs of meetings | 4,103 | - | 4,103 | 9,596 | - | 9,596 | ||||||
| Website expenses | 2,969 | - | 2,969 | 539 | - | 539 | ||||||
| Newsletter costs | 4,221 | - | 4,221 | 4,845 | - | 4,845 | ||||||
| Membership fulfilment | 12,520 | - | 12,520 | 26,924 | - | 26,924 | ||||||
| services | ||||||||||||
| Executive committee | 644 | - | 644 | |||||||||
| expenses | ||||||||||||
| Examiner’s | 3,770 | - | 3,770 | 3,522 | - | 3,522 | ||||||
| remuneration | ||||||||||||
| Miscellaneous | 459 | - | 459 | 492 | - | 492 | ||||||
| Subscriptions | 775 | - | 775 | 773 | - | 773 | ||||||
| Insurance | 126 | - | 126 | 95 | - | 95 | ||||||
| Total expenditure | 73,054 | 45,603 | 118,657 | 87,869 | 48,486 | 136,355 | ||||||
| Net | (7,165) | 26,897 | 19,732 | (24,346) | 14,014 | (10,332) | ||||||
| (expenditure)/income | ||||||||||||
| Transfer between | 4 | - | - | - | 1,324 | (1,324) | - | |||||
| funds | ||||||||||||
| Net movement in | (7,165) | 26,897 | 19,732 | (23,022) | 12,690 | (10,332) | ||||||
| funds | ||||||||||||
| Funds brought forward | ||||||||||||
| at 1 January 2025 | 185,220 | 40,712 | 225,932 | 208,242 | 28,022 | 236,264 | ||||||
| Funds carried | ||||||||||||
| forward at 31 | 178,055 | 67,609 | 245,664 | 185,220 | 40,712 | 225,932 | ||||||
| December 2025 |
P a g e | 10
THE BRITISH SOCIETY FOR CELL BIOLOGY BALANCE SHEET AS AT 31 DECEMBER 2025
| Current assets: Debtors 5 Cash at bank and in hand Liabilities: Accruals 6 Trade creditors Total assets less current liabilities 7 Funds Restricted funds 4 Unrestricted funds Total funds |
2025 2024 £ £ 3,395 700 256,117 240,386 259,512 241,086 3,770 3,530 10,078 11,624 13,848 15,154 245,664 225,932 67,609 40,712 178,055 185,220 245,664 225,932 |
2025 2024 £ £ 3,395 700 256,117 240,386 259,512 241,086 3,770 3,530 10,078 11,624 13,848 15,154 245,664 225,932 67,609 40,712 178,055 185,220 245,664 225,932 |
|---|---|---|
40,712 185,220 225,932 |
Approved by the Trustees 27/05/2026 and signed on their behalf by:
Laura Machesky Tobias Zech Trustee Trustee
P a g e | 11
THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. Accounting Policies
The Society is constituted under a constitution executed in 1965, and amended in 2014, 2022 and 2025. The Society is a registered charity, number 265816. Its registered office is C/O Prof T Zech, Institute of System, Molecular and Integrative Biology , University of Liverpool , Crown Street, L69 3BX. The Society meets the definition of a public benefit entity under FRS 102.
The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:
a) Basis of accounting
The financial statements are prepared in accordance with the charity’s constitution, the Charities Statement of Recommended Practice (Charities SORP 2019 (FRS 102)) and Financial Reporting Standard 102 (FRS 102). The financial statements are drawn up on the historical cost basis of accounting. The financial statements are prepared in sterling, which is the functional currency of the charity and rounded to the nearest £.
The trustees have prepared detailed forecasts and cashflow projections which they believe are based upon reasonable assumptions. The forecasts show that the charity should be able to operate for the foreseeable future and thus the trustees consider it appropriate to prepare the financial statements on a going concern basis.
b) Funds
General unrestricted funds represent the funds of the Society that are not subject to any restrictions regarding their use and are available for application on the general purposes of the Society.
Restricted funds are those subject to specific trusts, which may be declared by the donor or with their authority. The restricted funds of the Society are restricted income funds given for specific purposes, which are expendable at the discretion of the Executive Committee in accordance with particular activities of the Society.
c) Income
Voluntary income and donations (including legacies) are accounted for once the charity has entitlement to the income, it is probable the income will be received and the amount of income receivable can be reliably measured.
Subscriptions and mailing list sales represent amounts receivable during the year. Meetings income is recognised in the period when the meeting takes place and investment income (which represents interest on National Savings deposits and bank accounts) are the amounts receivable for the year.
d) Expenditure
Expenditure is accrued as soon as a liability is considered probable, discounted to present value for longer term liabilities.
Certain expenditure is directly attributable to specific activities and has been included in those cost categories. Support and governance costs attributable to more than one activity are apportioned across categories based on an estimate of the proportion of time spent by staff on those activities.
Grants and awards are accounted for when paid over, or when awarded, if that award creates a binding obligation on the charity.
P a g e | 12
THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025 (continued)
1. Accounting Policies (continued)
e) Joint arrangements
Where applicable the share of income and expenditure from joint arrangements to put on meetings in the year is accounted for under the appropriate heading in the Statement of Financial Activities.
f) Debtors
Grants receivable and other debtors are included at the settlement amount due. Prepayments are valued at the amount prepaid.
g) Cash at bank and in hand
Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of opening of the deposit.
h) Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation arising from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are recognised at their settlement amount.
i) Financial instruments
The charity only has financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
j) Foreign currency translation
Transactions in foreign currency are translated at the rate ruling on the date of the transaction. Balances denominated in foreign currencies are retranslated at the year-end, with the gain or loss on retranslation going through the Statement of Financial Activities for the year.
2.
Grants received
Grants of £107,500 (2024: £97,500) were received from The Company of Biologists during the year. £72,500 (2024: £62,500) of this was restricted as set out in Note 4 below, and £35,000 (2024: £35,000) was unrestricted.
3. Trustees/Officers and employees
No Trustees or any person connected with them, received, or is due to receive, any remuneration for the year directly or indirectly from the Society's funds.
There were eight Trustees paid in 2025 totalling £3,774 (2024: 11 trustees paid £6,106) in respect of reimbursed travel, subsistence, subscriptions, meetings, website expenses, membership and other expenses during the year. There were Nil third parties paid in 2025 (2024: nil) of costs for the Trustees to attend the Annual Spring Meeting. 1 (2024: 1) Trustee received Travel Grants of £1,000 (2024: £977).
The Society has no employees.
P a g e | 13
THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025 (continued)
4. Restricted funds
| 2025 Balance b/f £ Company of Biologists Operational Grant 40,712 CoB - PI Travel Fund CoB - Training Course Fund - Abercrombie Conference Fund - 40,712 |
Income Expenditure Transfers Balance c/f £ £ £ £ 72,500 (45,603) - 67,609 - - - - - - - - 72,500 (45,603) - 67,609 |
|---|---|
| 2024 | ||||||
|---|---|---|---|---|---|---|
| Balance b/f | Income | Expenditure | Transfers | Balance | c/f | |
| £ | £ | £ | £ | £ | ||
| Company of Biologists | ||||||
| Operational Grant | - | 62,500 | (48,486) | 26,698 | 40,712 | |
| CoB - PI Travel Fund | 21,055 | - | - | (21,055) | - | |
| CoB - Training Course Fund | 5,643 | - | - | (5,643) | - | |
| Abercrombie Conference Fund | 1,324 | - | - | (1,324) | - | |
| 28,022 | 62,500 | (48,486) | (1,324) | 40,712 |
The Company of Biologists Operational Grant are funds to be used for 3 grant types : Honor Fell Travel, PI Travel and Training Course grants. They also permitted previously unspent funds for these types of grants to be transferred into this fund in 2024.
The CoB - PI Travel Fund relates to grants made to BSCB Principal Investigators to enable them to travel to cell biology meetings – not just BSCB meetings, but also other meetings where cell biology is covered. The unspent funds on this fund were transferred to the Operational grant Fund in 2024.
The CoB - Training Course Fund relates to grants made to members to attend training courses. The unspent funds on this fund were transferred to the Operational grant Fund in 2024.
The Abercrombie Conference Fund was money held on behalf of the Trustees of the Abercrombie Conference Fund which will be used to sponsor meetings on cell motility. The transfer in 2024 reflects past expenditure which should have been allocated to this fund.
Further details of the awards made in the year are given in the Executive Committee’s Report.
P a g e | 14
THE BRITISH SOCIETY FOR CELL BIOLOGY NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025 (continued)
5. Debtors
| Prepayments and accrued income | 2025 £ 3,395 |
2024 £ 700 |
|---|---|---|
6. Creditors due within one year
| Accruals Other creditors 7. Analysis of net assets by fund Current assets Current liabilities At 31 December 2025 Current assets Current liabilities At 31 December 2024 |
Unrestricted Funds £ 191,903 (13,848) 178,055 Unrestricted Funds £ 200,374 (15,154) 185,220 |
2025 2024 £ £ 3,770 3,530 10,078 11,624 13,848 15,154 Restricted Total Funds Funds £ £ 67,609 259,512 - (13,848) 67,609 245,664 Restricted Total Funds Funds £ £ 40,712 241,086 - (15,154) 40,712 225,932 |
2025 2024 £ £ 3,770 3,530 10,078 11,624 13,848 15,154 Restricted Total Funds Funds £ £ 67,609 259,512 - (13,848) 67,609 245,664 Restricted Total Funds Funds £ £ 40,712 241,086 - (15,154) 40,712 225,932 |
|---|---|---|---|
| 245,664 | |||
| Total Funds £ 241,086 (15,154) 225,932 |